Prelude Capital Management, LLC Molecular Templates, Inc. Transaction History

Prelude Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$8.48 - $12.23 $6,784 - $9,784	-800 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.99 - $14.41 $7,992 - $11,528	800 New	800 $9,000
Q2 2018 Aug 14, 2018	SELL	$5.19 - $9.71 $3,114 - $5,826	-600 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.0 - $12.96 $4,800 - $7,776	600 New	600 $5,000
Q4 2017 Feb 14, 2018	SELL	$7.04 - $11.31 $6,336 - $10,179	-900 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.0 - $7.14 $4,500 - $6,426	900	900 $6,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $79.5M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.